Manipulation of Abro1 Localization in U2OS Cells
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Background

Results

When a replication fork stalls, that can lead to replicative stress
which decreases genomic stability and can lead to cancer1.
Abro1 has been found to be integral in protecting stalled
replication forks.
Abro1 has been found to localize both in the nucleus and in the
cytosol2. The purpose of this project is to generate Abro1 that
only localizes to one region, which is the first step in identifying
the differing Abro1 functions and determining whether they are
related. The mutants were generated with either a Nuclear
Localization Signal (NLS) or a Nuclear Export Signal (NES).
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Fig. 2 Western Blot results indicating that the Abro1-NLS and
Abro1-NES mutants were successfully generated with the
localization signals.
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Fig. 1 Generation of Abro1-NLS and Abro1-NES mutants. Mutants were generated
on the C-terminus region of Abro1.
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The successful generation of the two
Abro1 mutants is an important first step in
the understanding of Abro1. In the future,
these mutants could be used for further
testing of the different functions of Abro1
based on its localization and how these
functions interact. Thus, with a deeper
understanding of Abro1, we can have an
increased understanding of genome
stability which can have implications in
tumor suppression.
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Abro1-NLS and Abro1-NES were generated on pENTR-Abro1 by mutagenesis PCR.
DpnI was used to digest the DNA templates and the PCR products were then
transfected to E. Coli. The E. Coli was then spread on Luria Broth (LB) plates and
screened with antibiotics.

Mono-clones were sequenced to verify for correct DNA sequence

Abro1, Abro1-NLS, and Abro1-NES were transferred from pENTR vectors to
destination vectors which generated HA-Abro1, HA-Abro1-NLS, and HA-Abro1NES

DAPI

HA-Abro1, HA-Abro1-NLS, and HA-Abro1-NES recombination products were
transfected to E. Coli, spread on LB plates, and screened with antibiotics

Plasmids from HA-Abro1, HA-Abro1-NLS, and HA-Abro1-NES were extracted
from mono-clones

Fig. 3 Immunofluorescence results. The first column labeled HA serves as a negative control while the second column
labeled WT serves as a positive control. The NLS column shows that the NLS signal successfully localized Abro1 inside of
the nucleus while the NES column shows that the NES signal successfully localized Abro1 in the cytosol, outside of the
nucleus.

Transient expression of HA-Abro1, HA-Abro1-NLS, and HA-Abro1-NES occurred
in U2OS cells for 48 hours

Western blot performed in order to verify expression

Cells with fixed with 4% paraformaldehyde

Immunofluorescence was performed using rabbit anti-HA antibody and Alexa
Fluor™ Plus 488 conjugated anti-rabbit secondary antibody. A Confocal
microscope was used to take a photo of the results
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